Nuvalent (NUVL) EBITDA (2020 - 2026)

Nuvalent filings provide 7 years of EBITDA readings, the most recent being -$113.0 million for Q1 2026.

  • Quarterly EBITDA fell 35.04% to -$113.0 million in Q1 2026 from the year-ago period, while the trailing twelve-month figure was -$452.3 million through Mar 2026, down 51.43% year-over-year, with the annual reading at -$423.0 million for FY2025, 62.15% down from the prior year.
  • EBITDA hit -$113.0 million in Q1 2026 for Nuvalent, up from -$118.7 million in the prior quarter.
  • Across five years, EBITDA topped out at -$18.3 million in Q1 2022 and bottomed at -$121.4 million in Q3 2025.
  • Average EBITDA over 5 years is -$59.1 million, with a median of -$45.8 million recorded in 2024.
  • The largest annual shift saw EBITDA plummeted 170.3% in 2022 before it crashed 35.04% in 2026.
  • Nuvalent's EBITDA stood at -$25.8 million in 2022, then crashed by 43.49% to -$37.0 million in 2023, then crashed by 106.21% to -$76.2 million in 2024, then tumbled by 55.81% to -$118.7 million in 2025, then grew by 4.83% to -$113.0 million in 2026.
  • Per Business Quant, the three most recent readings for NUVL's EBITDA are -$113.0 million (Q1 2026), -$118.7 million (Q4 2025), and -$121.4 million (Q3 2025).